402 JOURNAL OF COSMETIC SCIENCE active after cessation of the treatments. We observed the activity of the treated melanocytes 6 months after treatment cessation. ACKNOWLEDGMENTS The authors thank the staff of Shinjuku Skin Clinic for their helpful technical supports. REFERENCES (1) T. Hirobe, How are proliferation and differentiation of melanocytes regulated? Pigment Cell Melanoma Res., 24(3), 462–478 (2011). (2) C. Bergqvist and K. Ezzedine, Vitiligo: A review, Dermatology, 236(6), 571–592 (2020). (3) K. K. Park, W. Liao, and J. E. Murase, A review of monochromatic excimer light in vitiligo, Br. J. Dermatol., 167(3), 468–478 (2012). (4) R. Li, M. Qiao, X. Wang, X. Zhao, and Q. Sun, Effect of narrow band ultraviolet B phototherapy as monotherapy or combination therapy for vitiligo: A meta-analysis, Photodermatol. Photoimmunol. Photomed., 33(1), 22–31 (2017). (5) T. Hirobe, H. Enami, and A. Nakayama, Elastin fiber but not collagen fiber is decreased dramatically in the dermis of vitiligo patients, Int. J. Dermatol., 59(10), e369–e372 (2020). (6) T. Hirobe, Ferrous ferric chloride stimulates the proliferation of human skin keratinocytes, melanocytes, and fibroblasts in culture, J. Health Sci., 55(3), 447–455, (2009). (7) J. Galipeau and L. Sensebe, Mesenchymal stromal cells: Clinical challenges and therapeutic opportunities, Cell Stem Cell, 22(6), 824–833 (2018). (8) A. Tyndall and F. A. Houssiau, Mesenchymal stem cells in the treatment of autoimmune diseases, Ann. Rheum. Dis., 69(8), 1413–1414 (2010). (9) L. Zhu, X. Lin, L. Zhi, Y. Fang, K. Lin, K. Li, and L. Wu, Mesenchymal stem cells promote human melanocytes proliferation and resistance to apoptosis through PTEN pathway in vitiligo, Stem Cell Res. Ther., 11(1), 26, (2020). (10) T. Hirobe and H. Enami, Excellent color-matched repigmentation of human vitiligo can be obtained by mini-punch grafting using a machine in combination with ultraviolet therapy, Dermatol. Sinica, 36(4), 203–206, (2018). (11) T. Hirobe and H. Enami, Histochemical study of the distribution of epidermal melanoblasts and melanocytes in Asian human skin, Skin Res. Technol., 25(3), 299–304 (2019). (12) A. Hachiya, A. Kobayashi, A. Ohuchi, Y. Takema, and G. Imokawa, The paracrine role of stem cell factor/c-kit signaling in the activation of human melanocytes in ultraviolet-B-induced pigmentation, J. Invest. Dermatol., 116(4), 578–586 (2001). (13) B. R. Weil, A. M. Abarbanell, J. L. Herrmann, Y. Wang, and D. R. Meldrum, High glucose concentration in cell culture medium does not acutely affect human mesenchymal stem cell growth factor production or proliferation, Am. J. Physiol. Regul. Integr. Comp. Physiol., 296(6), R1735– R1743 (2009). (14)Y .Yamaguchi, S. Itami, H. Watabe, K. I. Yasumoto, Z. A. Abdel-Malek, T. Kubo, F. Rouzaud, A. Tanemura, K. Yoshikawa, and V. J. Hearing, Mesenchymal–epithelial interactions in the skin: Increased expression of dickkopf1 by palmoplantar fibroblasts inhibits melanocyte growth and differentiation, J. Cell Biol., 165(2), 275–285 (2004). (15) T. Hirobe, Role of keratinocyte-derived factors involved in regulating the proliferation and differentiation of mammalian epidermal melanocytes, Pigment Cell Res., 18(1), 2–12 (2005).

403 MESENCHYMAL STEM CELL-DERIVED FACTORS (16) E. P. Kay, H. K. Lee, K. S. Park, and S. C. Lee, Indirect mitogenic effect of transforming growth factor- beta on cell proliferation of subconjunctival fibroblasts, Invest. Ophthalmol. Vis. Sci., 39(3), 481–486 (1998). (17) T. Ono, K. Mah, and F. Hu, Dermal melanocytes and elastic fibers, J. Cutan. Pathol., 12(6), 468–475 (1985). (18) C. H. Chang, Y. Kawa, R. K. Tsai, J. H. Shieh, J. W. Lee, H. Watabe, T. Kawakami, Y. Soma, S. Tajima, and M. Mizoguchi, Melanocyte precursors express elastin binding protein and elastin-derived peptide (VGVAPG) stimulates their melanogenesis and dendrite formation, J. Dermatol. Sci., 51(3), 158–170 (2008). (19) T. Hirobe and H. Enami, Elastin peptides with ferrous ferric chloride activate human melanocytes and elastin fibers, J. Skin Stem Cell, 9(2), e127254 (2022).